These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8100551)

  • 1. Immune-mediated mechanisms and immune activation of fibroblasts in the pathogenesis of eosinophilia-myalgia syndrome induced by L-tryptophan.
    Illa I; Dinsmore S; Dalakas MC
    Hum Pathol; 1993 Jul; 24(7):702-9. PubMed ID: 8100551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilia myalgia syndrome: I. Immunocytochemical evidence for a T-cell-mediated immune effector response.
    Emslie-Smith AM; Engel AG; Duffy J; Bowles CA
    Ann Neurol; 1991 May; 29(5):524-8. PubMed ID: 1859182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilia-myalgia syndrome: a clinicopathological study of four patients.
    Villanova M; De Clerck LS; Cras P; Ceuterick C; Van Marck E; Guazzi GC; Martin JJ
    Clin Neuropathol; 1993; 12(4):201-3. PubMed ID: 8403629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression in situ of selectin and immunoglobulin superfamily type adhesion molecules in retroocular connective tissues from patients with Graves' ophthalmopathy.
    Heufelder AE; Bahn RS
    Clin Exp Immunol; 1993 Mar; 91(3):381-9. PubMed ID: 7680294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent microvasculopathy in chronic eosinophilia-myalgia syndrome.
    Smith SA
    Adv Exp Med Biol; 1996; 398():359-64. PubMed ID: 8906289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cause and pathogenesis of the eosinophilia-myalgia syndrome.
    Varga J; Uitto J; Jimenez SA
    Ann Intern Med; 1992 Jan; 116(2):140-7. PubMed ID: 1727618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the pathology of fascia in eosinophilic myalgia syndrome patients and idiopathic eosinophilic fasciitis.
    Umbert I; Winkelmann RK; Wegener L
    Dermatology; 1993; 186(1):18-22. PubMed ID: 8435512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The eosinophilia-myalgia syndrome and eosinophilic fasciitis.
    Jimenez SA; Varga J
    Curr Opin Rheumatol; 1991 Dec; 3(6):986-94. PubMed ID: 1772754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,1'-Ethylidenebis[tryptophan] induces pathologic alterations in muscle similar to those observed in the eosinophilia-myalgia syndrome.
    Emslie-Smith AM; Mayeno AN; Nakano S; Gleich GJ; Engel AG
    Neurology; 1994 Dec; 44(12):2390-2. PubMed ID: 7991132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilia myalgia syndrome: absence of immunoglobulin reactivity suggests a cellular rather than humoral mechanism.
    Villanova M; De Clerck LS; Cras P; Guazzi GC; Martin JJ
    Acta Neurol Belg; 1994; 94(3):200-4. PubMed ID: 7976226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study on antibodies to nucleoli and 5-hydroxytryptamine in patients with fibromyalgia syndrome and tryptophan-induced eosinophilia-myalgia syndrome.
    Klein R; Berg PA
    Clin Investig; 1994 Jul; 72(7):541-9. PubMed ID: 7981584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A murine model of the eosinophilia-myalgia syndrome induced by 1,1'-ethylidenebis (L-tryptophan).
    Silver RM; Ludwicka A; Hampton M; Ohba T; Bingel SA; Smith T; Harley RA; Maize J; Heyes MP
    J Clin Invest; 1994 Apr; 93(4):1473-80. PubMed ID: 8163652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of the eosinophilia-myalgia syndrome].
    Ishikawa A; Akahosi T; Okada J; Kondo H; Kasiwazaki S
    Ryumachi; 1992 Aug; 32(4):327-30; discussion 330-2. PubMed ID: 1411794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of class II-MHC antigens in the dermis of patients with progressive systemic sclerosis.
    Gruschwitz M; Sepp N; Kofler H; Wick G
    Immunobiology; 1991 Jun; 182(3-4):234-55. PubMed ID: 1833311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased type I collagen gene expression in L-tryptophan associated eosinophilia-myalgia syndrome skin fibroblasts.
    Varga J; Li L; Jimenez SA
    J Rheumatol; 1993 Aug; 20(8):1303-8. PubMed ID: 8230009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Eosinophilic fasciitis (Shulman syndrome). Differential diagnosis of chronic eosinophilia-myalgia syndrome after L-tryptophan administration].
    Schnabel A; Reusch M; Christophers E; Gross WL
    Internist (Berl); 1994 Jan; 35(1):63-6. PubMed ID: 8144322
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathologic manifestations of the eosinophilia myalgia syndrome: analysis of 11 cases.
    Lin JD; Phelps RG; Gordon ML; Hilfer JB; Wolfe DE; Venkataseshan VS; Fleischmajer R
    Hum Pathol; 1992 Apr; 23(4):429-37. PubMed ID: 1563745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophilic perimyositis as the presenting feature of a monoclonal T-cell expansion.
    Dunand M; Lobrinus JA; Spertini O; Kuntzer T
    Muscle Nerve; 2005 May; 31(5):646-51. PubMed ID: 15770667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased activity of the alpha 1(I) procollagen promoter in skin fibroblasts from patients with chronic eosinophilia-myalgia syndrome.
    Hitraya EG; Jimenez SA; Ludwicka A; Silver RM; Varga J
    Int J Biochem Cell Biol; 1997 Jan; 29(1):135-41. PubMed ID: 9076948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tryptophan-induced lung disease: an immunophenotypic, immunofluorescent, and electron microscopic study.
    Tazelaar HD; Myers JL; Strickler JG; Colby TV; Duffy J
    Mod Pathol; 1993 Jan; 6(1):56-60. PubMed ID: 8426858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.